The most important financial indicators for the company Endoclat Med Srl - Unique Identification Number 22842832:
sales in 2023 was
29.162
euro, registering a net profit of
11.069
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 32.0%, from 22.156 euro in the year 2022, to 29.162 euro in 2023.
The Net Profit decreased by -1.228 euro, from 12.334 euro in 2022, to 11.069 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Endoclat Med Srl - CUI 22842832
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
15.189
15.315
15.159
14.903
14.629
14.346
14.074
13.762
13.805
13.763
Current Assets
8.749
1.160
2.657
12.403
17.952
23.071
4.008
10.533
2.711
6.236
Inventories
0
0
0
0
43
0
662
647
649
647
Receivables
1.050
1.054
2.550
3.179
1.104
1.124
2.102
1.356
1.472
1.824
Cash
7.699
105
107
9.224
16.805
21.947
1.244
8.530
590
3.766
Shareholders Funds
10.378
7.302
14.214
24.948
30.896
36.125
13.036
23.032
13.132
16.074
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
13.639
9.253
3.682
2.435
1.761
1.367
5.119
1.335
3.456
3.997
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
6.236 euro in 2023 which includes Inventories of
647 euro, Receivables of
1.824 euro and cash availability of
3.766 euro.
The company's Equity was valued at
16.074 euro, while total Liabilities amounted to
3.997 euro.
Equity increased by 2.982 euro, from 13.132 euro in 2022, to 16.074 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Endoclat Med Srl